Medical miracle brings limbs back to life
The incredible story of Adrian Walsh, featuring Orthocell’s CelGro™ nerve treatment, has been featured in the Weekend Australian.
November 20, 2020
HCP Webinar | Latest Developments in the Biological Treatment of Cartilage – Professor Martin Sullivan
Professor Martin Sullivan Foot and Ankle Surgeon at St. Vincent’s Clinic & North Shore Private Hospital in Sydney presents ‘An Australian Perspective on the Management of Large Cartilage Defects in the Ankle Over 25 Years’
November 10, 2020
Video | Proactive Investors Interview – September 2020
Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about the company being in an exciting regulatory phase, having validated its technologies in the clinic and defining pathways to market through the US FDA process.
September 22, 2020
Australia’s Orthocell submits 510(k) for Celgro™ regenerative collagen medical device
Orthocell has been featured in BioWorld, following the submission of a 510(k) application to the U.S. FDA for our Celgro™ collagen medical device for dental guided bone and soft tissue regeneration applications.
May 22, 2020
Orthocell looks to enter US market following positive CelGro™ study results
Small Caps has featured Orthocell’s plans to enter the US market following the success of our Celgro™ dental implant study.
March 11, 2020
Orthocell – The Next Big Winner In The Regenerative Sector
Greg Tolpigin has published positive commentary about the future of Orthocell, and the potential for our CelGro™ product in this article on Sharecafe.
November 29, 2019
Orthocell receives patent for breakthrough CelGro ‘collagen rope’ to treat ACL injuries
Small Caps has reported on Orthocell’s recent patent announcement for our breakthrough CelGro collagen rope device to enhance the surgical repair of anterior cruciate ligament (ACL) injuries.
November 12, 2019
Australia’s Orthocell ready to file on interim Celgro™ data
BioWorld has reported on Orthocell’s plans to seek early FDA approval for our Celgro™ nerve regeneration treatment, following positive interim clinical results in quadriplegic patients.
October 16, 2019
Orthocell shares boosted by nerve repair trial success
Journalist Sarah Jane Tasker, from The Australian, discusses the positive results from Orthocell’s clinical trial of nerve repair product, CelGro™, in quadriplegic patients.
October 9, 2019
Orthocell on course to revolutionise nerve regeneration after positive interim clinical results
Orthocell has been featured in Small Caps following positive interim clinical results for CelGro™, a collagen medical device that facilitates tissue repair and healing in a variety of orthopaedic, reconstructive and surgical applications.
October 9, 2019